Reuters: Health
Roche said a new port delivery system (PDS) for its eye drug Lucentis was as good as monthly injections in blindness-causing macular degeneration, as the Swiss drugmaker aims to refresh its older blockbuster medicine as new rivals press in.
No comments:
Post a Comment